The Biomedical HIV Prevention Summit will be held December 3-4, 2019 at the Marriott Marquis Houston in Houston, Texas. Registration for the Summit is officially open!
NMAC believes we must highlight the role that biomedical prevention tools such as PrEP, PEP, Treatment as Prevention (TasP), and U=U have in ending the epidemic. This meeting brings HIV leaders together to discuss and learn about biomedical HIV prevention interventions. The conversations held at the Summit will focus on the effective implementation and the need for important infrastructure to turn the promise of new, scientific innovations into effective community-level HIV prevention options for communities most in need.
NMAC thanks Gilead for recommitting their support of this important meeting.